Feature | February 01, 2021| By Dave Fornell, Editor

Most Popular Cardiology Technology Content in January 2021 

The most popular story in the month of January 2021 was on a small study that showed the new iPhone 12 can cause ICDs to stop functioning. COVID-19 content continues to rank among the top stories, including an article on the possible long-term cardiac consequences of COVID-19 infection in COVID long-haulers. 

February 1, 2021 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) magazine website from the month of January 2021. This is based on the website’s record 726,770 pageviews for the month. 

1. iPhone 12 May Cause Implantable Cardioverter Defibrillators to Malfunction

2. FDA Says New COVID Virus Mutation May Cause False Negatives

3. Image Gallery Showing Impact of the COVID-19 Pandemic

4. The Long-term Cardiovascular Impact of COVID-19

5. Wireless Transcutaneous Energy Transfer (TET) System for Powering a LVAD is Successful

6. FDA Grants Break Through Device Designation for TricValve Transcatheter Bicaval Valves System

7. Interventional X-ray Equipment Markets Plummeted in 2020 Due to COVID

8. Cardiac Monitoring in the Time of COVID-19

9. Top 25 Stories in Cardiology in 2020

10. NIH Pauses Anticoagulant Trial For Critically Ill COVID-19 Patients

11. Medicare Expands Coverage for MitraClip in Heart Failure Patients

12. Who Qualifies for the COVID Vaccine Under CDC Guidelines

13. FDA Approved Second COVID-19 Vaccine From Moderna

14. FDA Clears Ultromics Echocardiography AI for Automated Identification of Coronary Artery Disease

15. TAVR Is Now Dominant Form of Aortic Valve Replacement in the United States

16. VIDEO: Rising Interest in Remote Monitoring of EP Devices in the COVID-19 Era

17. FDA Clears Boston Scientific Synergy Megatron Drug-eluting Stent for Proximal, Fibrotic and Calcified Lesions

18. 8 Top Trend Takeaways in Medical Imaging From RSNA 2020

19. Edwards Sapien 3 TAVR Valve Receives Expanded Approval in Canada

20. FDA Clears Vericiguat to Treat Heart Failure Following Hospitalization

21. Canada Clears Medtronic Evolut TAVR for Both Bicuspid Valves and for All Low Risk Patients

22. Occlutech's Atrial Flow Regulator for Heart Failure Receives FDA Breakthrough Device Designation

23. 3-D Printing and Computer Aided Design Aids Structural Heart Interventions

24. First Patient Treated With Harpoon Transcatheter Mitral Valve Repair Device in U.S. Trial 

25. Long-term Outcomes After Coronary Bypass Show Worse Outcomes for Women

 

Related Popular Cardiology Technology Content: 

Most Popular Cardiology Technology Content in December 2020

Top 25 Stories in Cardiology in 2020

Top 25 Cardiology Videos on DAIC in 2020

Most Popular Cardiology Technology Content in November 2020

 

Related Content

Vaccinating patients against the flu can go a long way to helping cardiology patients stay healthy and out of the hospital during the COVID-19 pandemic, freeing up beds for COVID patients. Left photo, Getty Images, right image of COVID-19 virus from the NIH.

Vaccinating patients against the flu can go a long way to helping cardiology patients stay healthy and out of the hospital during the COVID-19 pandemic, freeing up beds for COVID patients. Left photo, Getty Images, right image of COVID-19 virus from the NIH.

Feature | Coronavirus (COVID-19) | February 23, 2021 | By William Schaffner, M.D., and Allen J. Taylor, M.D.
While influenza (flu) is unpredictable, the 2020-2021 influenza season may present an unprecedented dual threat: co-c
The FDA says scientific evidence does not support COVID (coronavirus, SARS-CoV-2) transmission via food or packaging. Getty Images #COVID #COVID19 #SARSCoV2

The FDA says scientific evidence does not support COVID transmission via food or packaging. Getty Images

News | Coronavirus (COVID-19) | February 19, 2021
February 19, 2020 — After more than a year since the...
News | Coronavirus (COVID-19) | February 16, 2021
February 16, 2021 — Crystal Gutierrez, a young mother who earlier in 2020 fell seriously ill from the effects of...
Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images

Cardiologists are taking a closer look at the possible long-term cardiovascular effects on COVID long-hauler patients who still show symptoms long after they should be recovered from the virus. Getty Images

Feature | Coronavirus (COVID-19) | January 22, 2021 | Dave Fornell, Editor
With nearly a year of experience with the...
A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images

A recent Society for Cardiovascular Angiography and Interventions (SCAI) survey found nearly 40 percent of Americans still do not feel safe going to the doctor's office while coronavirus is still a risk. Survey respondents also said they are more afraid of catching the virus than they are of a heart attack or stroke, which may delay critical treatment. Getty Images

News | Coronavirus (COVID-19) | January 18, 2021
January 18, 2021 — According to a new national survey released Jan.
Myocarditis among recovering COVID-19 athletes less common than previously reported

Myocarditis among recovering COVID-19 athletes appears to be less common than previously reported. Getty Images

News | Coronavirus (COVID-19) | January 12, 2021
January 11, 2021 — In a letter published in the December issue of the American Heart Association (AHA) ...
The AHA and American Medical Society for Sports Medicine are collaborating to evaluate impact of COVID on the hearts of athletes, improve detection and inform safe return to play. #COVID19

The AHA and American Medical Society for Sports Medicine are collaborating to evaluate impact of COVID on the hearts of athletes, improve detection and inform safe return to play. Getty Images

News | Coronavirus (COVID-19) | January 12, 2021
January 12, 2021 — The American Heart Association (AHA) and the Ameri...
While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern. FDA warns PCR tests may be innaccurate with new UK virus varient.

While the FDA said the risk that SARS-CoV-2 virus mutations will only have a minor impact on testing accuracy is low, the agency singled out three tests are they had a higher concern.

Feature | Coronavirus (COVID-19) | January 08, 2021 | Dave Fornell, Editor
January 8, 2021 — The U.S.
Who Can Get the COVID-19 Vaccine? Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, a nurse at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

Roberto Lang, M.D., director of noninvasive cardiac imaging, University of Chicago Medical Center and former American Society of Echocardiography (ASE) president, received his first dose of the COVID vaccine in December. In addition to front line hospital workers, nursing home staff and residents also qualified for the first round of vaccinations. Right, Shannon Yaw, OTR/L, director of rehabilitation at a hard-hit nursing home in Michigan, received her first dose just before Christmas.

News | Coronavirus (COVID-19) | January 04, 2021 | Dave Fornell, Editor
The Centers for Disease Control and Prevention (CDC) Dec.
Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al.

Thrombus formation in the aortic arch in a 46-year-old COVID patients in the ICU. Three trials are underway to find which anticoagulant strategy is best to treat moderate and critically ill patients where COVID-causes venous thrombo-embolism (VTE) is a major cause of complications. Image courtesy of Margarita Revzin et al. 

Feature | Coronavirus (COVID-19) | December 23, 2020
December 23, 2020 — Three clinical trial platforms working together to test the effects of full doses of anticoagulan